Azione 300791 SIRIO PHARMA CO., LTD.
Aggiungi a un elenco
Solo clienti o iscritti possono usare questa funzione
AccediRegistrati

Altre lingue Sirio Pharma Co., Ltd.

Azioni

300791

CNE100003NB0

Prezzo di chiusura Shenzhen S.E.
Altri mercati azionari
 00:00:00 10/05/2024 		Variaz. 5gg Var. 1 gen.
41,69 CNY -0,88% Grafico intraday di Sirio Pharma Co., Ltd. +6,82% +20,28%
21/04 Sirio Pharma Co., Ltd. riporta i risultati degli utili per il primo trimestre conclusosi il 31 marzo 2024 CI
2023 Sirio Pharma Co., Ltd. riporta i risultati degli utili per i nove mesi conclusi il 30 settembre 2023 CI

Altre lingue

Ricerca
Vedi i risultati
Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!
Registrazione 100% gratuita
Sirio Pharma Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024
Tranche Update on Sirio Pharma Co., Ltd.'s Equity Buyback Plan announced on September 15, 2023.
Sirio Pharma Co., Ltd.'s Equity Buyback announced on September 15, 2023, has closed with 1,285,600 shares, representing 0.71% for CNY 39.9 million.
Tranche Update on Sirio Pharma Co., Ltd.'s Equity Buyback Plan announced on September 15, 2023.
Sirio Pharma Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023
Certain A-Shares of Sirio Pharma Company Limited are subject to a Lock-Up Agreement Ending on 25-SEP-2023.
Sirio Pharma Co., Ltd.(XSEC:300791) added to S&P Global BMI Index
Sirio Pharma Co., Ltd. announces an Equity Buyback for CNY 40 million worth of its shares.
Sirio Pharma Co., Ltd. authorizes a Buyback Plan.
Sirio Pharma Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023
Sirio Pharma Co., Ltd. Announces Implementation of Cash Dividend for the Year 2022, Payable on June 07, 2023
Sirio Pharma Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023
Sirio Pharma Co., Ltd. Proposes Profit Distribution Proposal of Cash Dividend for the Year 2022
Sirio Pharma Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022
Sirio Pharma Co., Ltd.(XSEC:300791) dropped from S&P Global BMI Index
Sirio Pharma Cancels Planned 1.35 Billion Yuan Share Sale to Fund Aquisition
Sirio Pharma Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022
Sirio Pharma Co., Ltd. acquired 80% stake in Best Formulations Inc. from m Eugene C. Ung, Kelly C. Ung, Charles C. Ung, Peak Trust Company-NV, Jeffrey A. Goh, and Joy S. Hsu.
Certain A-Shares of Sirio Pharma Company Limited are subject to a Lock-Up Agreement Ending on 25-SEP-2022.
Sirio Pharma Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022
Non ci sono risultati per questa ricerca
Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Filtri

Cerca

Data di pubblicazione

Da

A

  1. Borsa valori
  2. Azioni
  3. Azione 300791
  4. Notizie Sirio Pharma Co., Ltd.
  5. Altre lingue